Source/Disclosures Published by: Disclosures: The authors report no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . […]
Breast Cancer
Everything you need to know about pregnancy-associated breast cancer
Dr Fatima Hoosain is a specialist surgeon at Apffelstaedt & Associates with a particular interest in breast and thyroid health. Here, she speaks about pregnancy-associated breast cancer, sharing information on the risks, treatment and what it all means for the baby. Pregnancy-associated breast cancer (PABC) is defined as breast cancer […]
Mammographic Breast Density, Benign Breast Disease, and Subsequent Breast Cancer Risk in 3.9 Million Korean Women
Summary Women with dense breasts and benign breast disease had an elevated risk of future breast cancer and could benefit from a tailored mammography screening strategy. Key Results ■ Among 3.9 million women, breast cancer risk was 1.36% in women with fatty breast tissue (Breast Imaging Reporting and Data System […]
Breast Cancer Liquid Biopsy Market 2022-2026 | Growing Prevalence of Breast Cancer Cases to Boost Growth
To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Breast Cancer Liquid Biopsy Market 2022-2026: Segmentation The breast Cancer Liquid Biopsy Market is segmented as below: By Product Type Reagent Kits […]
Karmanos Cancer Institute and the Detroit Tigers honor survivors and promote breast health at 10th Annual Pink Out the Park game
Throughout the game and in the Comerica Park concourse, fans will have the opportunity to engage with several activities, including a ceremonial first pitch, in-game awareness promotions, and an on-field recognition ceremony honoring members of the Karmanos Breast Cancer Multidisciplinary Team. Tigers fans will have the opportunity to honor a […]
Nivolumab Plus Trastuzumab Deruxtecan Provides No Perceptible Clinical Benefit Over ADC Alone in Advanced HER2+ Breast Cancer
The addition of nivolumab to trastuzumab deruxtecan did not result in a marked clinical benefit in patients with locally advanced unresectable or metastatic HER2-positive breast cancer. The addition of nivolumab (Opdivo) to fam-trastuzumab deruxtecan-nxki (Enhertu) did not result in a marked clinical benefit in patients with locally advanced unresectable or […]
Vitamin D may reduce risk in Black and Hispanic women
Share on PinterestNew research highlights the importance of healthy vitamin D levels in Black and Hispanic women. gorodenkoff/Getty Images Vitamin D deficiency is increasing and people with dark skin living in the Northern hemisphere are particularly affected. Deficiency is increasingly being linked to various diseases including breast cancer. A study […]
How new Insights into ESR1 Mutant Breast Cancers may lead to Novel Therapy Targets
In this interview, we speak to Steffi Oesterreich, PH.D., from the University of Pittsburgh, about how new insights into a gene mutation present in 20-30% of breast cancer recurrences may have a silver lining, leading to novel treatment opportunities. Please can you introduce yourself, tell us about your background in […]
Study Results Help Define New Factors That Can Predict Breast Cancer Recurrence
Discovery has the potential to also benefit treatment choices, investigators from Georgetown Lombardi Comprehensive Cancer Center say. Genetic and other factors can be used to determine if a woman is at risk for a recurrence of breast cancers, according to investigators at Georgetown Lombardi Comprehensive Cancer Center. The discovery was […]
Quantifying dietary acid load in U.S. cancer survivors: an exploratory study using NHANES data | BMC Nutrition
Banerjee T, Crews DC, Wesson DE, Tilea A, Saran R, Rios Burrows N, et al. Dietary acid load and chronic kidney disease among adults in the United States. BMC Nephrol. 2014;15(1):137. Article CAS PubMed PubMed Central Google Scholar Kahleova H, McCann J, Alwarith J, Rembert E, Tura A, Holubkov R, […]
NanOlogy Publishes Results from a Phase 1/2 Clinical Trial of its Topical Investigational Drug in the Treatment of Cutaneous Metastases of Breast Cancer
FORT WORTH, Texas–(BUSINESS WIRE)–NanOlogy LLC, a clinical-stage interventional oncology drug company, announced today that results from a clinical trial of topical submicron particle paclitaxel (SOR007) in cutaneous metastases of breast cancer (CMBOC) have been published in Breast Cancer Research and Treatment. The research article entitled Phase 1/2 Study of Topical […]
TROP2 as patient-tailoring but not prognostic biomarker
Introduction With more than 2.3 million estimated new cases in 2020, breast cancer (BC) is the most commonly diagnosed cancer (~24.5%) and the leading cause of cancer death (~15.5%) in women.1 Clinically, BC can be divided into different subtypes by their histopathological appearance and expression status of the estrogen receptor […]